CA

Craig A. Dais

Chief Financial Officer

Navidea Biopharmaceuticals

Navidea Biopharmaceuticals Pipeline

DrugIndicationPhase
Tc99m TilmanoceptLymphatic Mapping (Breast Cancer, Melanoma)Approved
Manocept DiagnosticKaposi's SarcomaPreclinical/Phase 1
Manocept TherapeuticOncology / Inflammatory DiseasesResearch